Search Results
TBPB 10 mg | Purity Not Available
TargetMol
WZ811 5 mg | 99.93%
TargetMol

WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
More Information Supplier PageWZ811 50 mg | 99.93%
TargetMol

WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
More Information Supplier PageVarenicline Tartrate 10 mg | Purity Not Available
TargetMol

Varenicline tartrate is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
More Information Supplier PageVarenicline Tartrate 5 mg | Purity Not Available
TargetMol

Varenicline tartrate is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
More Information Supplier PageNateglinide 10 mg | 99.78%
TargetMol

Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information Supplier PageNateglinide 25 mg | 99.78%
TargetMol

Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information Supplier PageMontelukast sodium 100 mg | 99.35%
TargetMol

Montelukast sodium is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
More Information Supplier PageMontelukast sodium 50 mg | 99.35%
TargetMol

Montelukast sodium is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
More Information Supplier Page